PUBLISHER: The Business Research Company | PRODUCT CODE: 2165581
PUBLISHER: The Business Research Company | PRODUCT CODE: 2165581
An oocyte collection system is a medical device system used in assisted reproductive procedures to retrieve oocytes from ovarian follicles under controlled clinical conditions. It is designed to provide precise follicular access, controlled aspiration, and secure transfer of retrieved biological material while maintaining sterility, pressure stability, and temperature-controlled handling conditions. The system supports minimally invasive reproductive procedures by ensuring consistent fluid dynamics, sample integrity, and procedural safety during oocyte retrieval.
The primary product types of oocyte collection systems include aspiration needles, single lumen needles, double lumen needles, vacuum aspiration pumps, suction tubing sets, oocyte collection tubes, collection chambers, and follicle flushing systems. Aspiration needles refer to specialized sterile needles used during oocyte retrieval procedures to aspirate follicular fluid and collect oocytes from ovarian follicles under ultrasound guidance. These systems incorporate technological modalities such as automated aspiration systems, fully automated systems, semi-automated systems, manual systems, and handheld variants and are available in disposable and reusable configurations. They are distributed through direct sales, medical device distributors, online sales channels, specialty medical suppliers, and other channels and are utilized by end users including fertility clinics and assisted reproductive technology centers, hospitals with reproductive medicine departments, cryobanks and egg banking facilities, and research and academic institutes.
Tariffs are influencing the oocyte collection system market by raising the cost of imported aspiration needles, vacuum aspiration pumps, ultrasound-guided components, sterile consumables, and precision medical devices used in oocyte retrieval procedures. This is increasing procurement expenses and delaying equipment upgrades, particularly in regions such as Asia-Pacific and Latin America that depend on imported medical technologies. Product segments including aspiration needles, vacuum aspiration pumps, follicle flushing systems, and fertility clinics are most affected due to their dependence on global supply chains. However, tariffs are also promoting domestic medical device manufacturing, regional supplier diversification, and increased investment in local reproductive healthcare equipment production, supporting long-term market resilience.
The oocyte collection system market research report is one of a series of new reports from The Business Research Company that provides oocyte collection system market statistics, including oocyte collection system industry global market size, regional shares, competitors with a oocyte collection system market share, detailed oocyte collection system market segments, market trends and opportunities, and any further data you may need to thrive in the oocyte collection system industry. This oocyte collection system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The oocyte collection system market size has grown rapidly in recent years. It will grow from $6.17 billion in 2025 to $7.17 billion in 2026 at a compound annual growth rate (CAGR) of 16.3%. The growth during the historic period can be attributed to growing demand for assisted reproductive technologies, increasing infertility treatment procedures, rising adoption of minimally invasive fertility procedures, expansion of fertility clinic infrastructure, and increasing awareness of reproductive health services.
The oocyte collection system market size is expected to see rapid growth in the next few years. It will grow to $12.91 billion in 2030 at a compound annual growth rate (CAGR) of 15.8%. The growth during the forecast period can be attributed to rising demand for advanced oocyte retrieval systems, increasing investment in fertility treatment infrastructure, growing adoption of automated aspiration technologies, expanding access to assisted reproductive services, and greater emphasis on improving oocyte retrieval efficiency. Major trends during the forecast period include increasing adoption of minimally invasive oocyte retrieval procedures, rising demand for precision follicular aspiration systems, greater focus on sterile single-use collection devices, expansion of temperature-controlled sample handling solutions, and increasing preference for integrated oocyte retrieval workflows.
The increasing global infertility rates are expected to propel the growth of the oocyte collection system market going forward. Infertility refers to the inability to achieve pregnancy after a prolonged period of regular, unprotected intercourse, and its prevalence is increasing across both developed and developing regions. Infertility rates are rising due to delayed parenthood, as individuals are increasingly choosing to have children at older ages, while natural fertility declines with age, particularly among women, due to reductions in both the quantity and quality of eggs, making conception more difficult. Oocyte collection systems are used to facilitate the safe and efficient retrieval of mature eggs from a woman's ovaries during assisted reproductive procedures such as IVF, thereby improving the chances of successful fertilization and conception among individuals affected by declining fertility rates. For instance, in April 2023, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, approximately 17.5% of the adult population, or about 1 in 6 people globally, experience infertility, highlighting the need to improve access to affordable, high-quality fertility care for affected individuals. Therefore, the increasing global infertility rates are driving the growth of the oocyte collection system market.
Major companies operating in the oocyte collection system market are concentrating on innovations in aspiration needle design, including enhanced echogenic surface technology, to help clinicians perform oocyte retrieval with greater precision and lower procedural risk. Enhanced echogenic surface technology refers to a needle surface treatment that improves the visibility of the needle tip under ultrasound guidance, enabling clinicians to track its position throughout the retrieval procedure. For instance, in November 2025, Rocket Medical plc, a UK-based medical device company, introduced the Embryon SX single lumen aspiration needle to improve oocyte retrieval accuracy and ultrasound-guided visualization during IVF procedures while enhancing procedural control and reducing patient trauma. The needle incorporates a spiral echo bevel design for high-resolution ultrasound definition, a shaped finger grip with a bevel marker to support procedural control, and an Oxford tubing set with a clear silicone bung for secure connection to the aspiration line.
In October 2023, Hamilton Thorne Ltd., a Canada-based precision instruments and assisted reproductive technology (ART) company, acquired Gynetics Medical Products N.V. for an undisclosed amount. Through this acquisition, Hamilton Thorne Ltd. aims to strengthen and broaden its consumables and clinical product portfolio in the global IVF and assisted reproductive technology market by adding high-quality, recurring-revenue IVF consumables, expanding its presence in the European ART sector, and leveraging synergies between its existing distribution channels and Gynetics' established embryo transfer and ovum pick-up product lines to support broader international commercialization and long-term revenue growth in fertility care solutions. Gynetics Medical Products N.V. is a Belgium-based medical device company that specializes in designing and manufacturing oocyte collection systems.
Major companies operating in the oocyte collection system market are CooperSurgical Inc., Vitrolife AB, Nexpring Health, Genea Biomedx, Esco Medical ApS, Rocket Medical plc, BIRR BioSciences B.V., SparMED ApS, Laboratoire CCD S.A.S., Labotect GmbH, MedGyn Products Inc., Vitromed GmbH, RI.MOS S.r.l., Gynotec B.V.
North America was the dominant region in the oocyte collection system market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the oocyte collection system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the oocyte collection system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The oocyte collection system market consists of sales of integrated oocyte retrieval systems, closed fluid handling systems, aspiration control units, collection and transfer assemblies, sterile collection kits, and associated supporting device configurations. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Oocyte Collection System Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses oocyte collection system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for oocyte collection system ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The oocyte collection system market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.